Revolution Medicines (RVMD) Stock Forecast & Price Target
Score
Revolution Medicines, Inc. price target
| RVMD | |
|---|---|
| Low | $179.00 |
| Average | $253.47 |
| High | $320.00 |
| Upside vs current price | +40.3% |
The average target of $253.47 is +40.3% versus the current RVMD price of $180.70.
Revolution Medicines, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 5 |
| Buy | 19 |
| Hold | 1 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
25 analysts cover RVMD.
Revolution Medicines, Inc. EPS and revenue estimates
The estimate table for the Revolution Medicines, Inc. keeps 2026 EPS $-9.49, 2027 EPS $-5.79, and years with fewer than three analysts are not filled in.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $-9.49 | $208.04M |
| 2027 | $-5.79 | $1.23B |
Is Revolution Medicines, Inc. a buy or sell?
Of the 25 analysts covering Revolution Medicines, Inc., 24 rate it a buy (5 strong buy and 19 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The RVMD consensus label is Buy, beside 24 buy-side ratings and 0 sell-side ratings.
The average target of $253.47 implies +40.3% versus the current price of $180.70.
the Revolution Medicines, Inc. closes with 24 buy-side ratings and 0 on the sell side. The headcount is Buy.
Reading the Revolution Medicines, Inc. forecast
Analysts are far apart on RVMD. The published low is $179.00, the average is $253.47, and the high is $320.00.
From today's $180.70 print, the RVMD average target is +40.3% away.
Most of the RVMD coverage agrees: 24 of 25 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.
RVMD targets have not moved much: $250.00 recently, $249.08 across the quarter.
Coverage of RVMD is broad at 25 analysts, and the average is a crowd rather than a single desk.
Revolution Medicines, Inc. forecast questions
What is the RVMD price target?
The published range for RVMD is $179.00 to $320.00, with an average of $253.47. That average is +40.3% versus the current price of $180.70.
Is Revolution Medicines, Inc. a buy or sell?
Of the 25 analysts covering Revolution Medicines, Inc., 24 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, which for RVMD is 24 on the buy side, 1 at hold, and 0 on the sell side.
What is the EPS estimate for Revolution Medicines, Inc.?
Analyst EPS estimates for Revolution Medicines, Inc.: 2026 $-9.49, 2027 $-5.79.
What is the revenue estimate for Revolution Medicines, Inc.?
Analyst revenue estimates for Revolution Medicines, Inc.: 2026 $208.04M, 2027 $1.23B.
How many analysts cover RVMD?
25 analysts cover RVMD. Their consensus on RVMD is Buy, across those 25.